HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

Supplement/OTC drug manufacturer reaches agreement in principle with lenders to extend forbearance deadline until Sept. 28. Extension enables company to continue push toward permanent financial restructuring plan (1"The Tan Sheet" Aug. 20, p. 9)

You may also be interested in...

Leiner Sales, Gross Profit Advances Reflect Restructuring Initiatives

Leiner Health Products' ongoing restructuring efforts appear to be paying dividends as the firm's net sales jumped 7.2% to $139.5 mil. for the first quarter ended June 30.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts